This Chewy Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Benzinga·09/25 11:26
Share
Listen to the news
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
BMO Capital analyst Kelly Bania upgraded United Natural Foods, Inc. (NYSE: UNFI) from Market Perform to Outperform and raised the price target from $25 to $36. United Natural Foods shares closed at $29.16 on Wednesday. See how other analysts view this stock.
Morgan Stanley analyst Bob Huang upgraded Slide Insurance Holdings, Inc. (NASDAQ: SLDE) from Equal-Weight to Overweight and maintained the price target of $18. Slide Insurance shares closed at $14.06 on Wednesday. See how other analysts view this stock.
Leerink Partners analyst David Risinger upgraded the rating for Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) from Market Perform to Outperform but lowered the price target from $458 to $456. Vertex Pharmaceuticals shares closed at $376.62 on Wednesday. See how other analysts view this stock.
MoffettNathanson analyst Michael Morton upgraded Chewy, Inc (NYSE: CHWY) from Neutral to Buy and announced a $48 price target. Chewy shares closed at $37.40 on Wednesday. See how other analysts view this stock.
Wells Fargo analyst Colin Langan upgraded the rating for Adient plc (NYSE: ADNT) from Equal-Weight to Overweight and raised the price target from $24 to $31. Adient shares closed at $24.32 on Wednesday. See how other analysts view this stock.
Considering buying CHWY stock? Here’s what analysts think:
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.